1 February 2016 in British Journal of Anaesthesia
The aim was to evaluate the analgesic efficacy and safety of the dexketoprofen/tramadol 25 mg/75 mg fixed-dose combination vs dexketoprofen (25 mg) and tramadol (100 mg) in moderate-to-severe acute pain after total hip arthroplasty. This was a randomized, double-blind, parallel-group study in patients experiencing pain of at least moderate intensity on the day after surgery, compared with placebo at first administration to validate the pain model. The study drug was administered orally every 8 h throughout a 5 day period. Rescue medication, metamizole 500 mg, was available during the treatment period. The evaluation of efficacy was based on patient assessments of pain intensity and pain relief. The primary end point was the mean sum of the pain intensity difference values throughout the first 8 h (SPID8). Overall, 641 patients, mean age 62 (range 29-80) yr, were analysed; mean (sd) values of SPID8 were 247 (157) for dexketoprofen/tramadol, 209 (155) for dexketoprofen, 205 (146) for tramadol, and 151 (159) for placebo. The primary analysis confirmed the superiority of the combination over dexketoprofen 25 mg (P=0.019; 95% confidence interval 6.4-73) and tramadol 100 mg (P=0.012; 95% confidence interval 9.5-76). The single components were superior to placebo (P<0.05), confirming model sensitivity. Most secondary analyses supported the superiority of the combination. The incidence of adverse drug reactions was low and similar among active treatment groups. The efficacy results confirmed the superiority of dexketoprofen/tramadol over its single components, even at higher doses (tramadol), with a safety profile fully in line with that previously known for these agents in monotherapy. EudraCT 2012-004548-31 (https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-004548-31);ClinicalTrials.gov NCT01902134 (https://www.clinicaltrials.gov/ct2/show/NCT01902134?term=NCT01902134&rank=1).
1 April 2022 in Prosthetics and Orthotics International
Background: Sensory feedback between a device and its user helps to improve the effectiveness of control and training processes. These improvements involve corrective actions and the accumulation of experience to accelerate patient training in device control. Objectives: Vibrations from rehabilitation devices are used as sensory feedback signals for improving rehabilitation outcomes. Study design: Variations in the bone-anchored prosthesis frequency responses and vibration transmissibility under compressive loading were studied. Methods: Five laboratory samples consisting of the above-knee prosthesis, custom-made implant, and cadaver bone were first axially compressed using universal testing machine; preloaded construction vibrations were generated with a shaker to imitate external forces acting on these samples. The oscillations at the sample surface control points were tested with a laser vibrometer. For different values of axial loading, the frequency responses of the samples and indexes of vibration attenuation were obtained to examine the correlations between vibration transmissibility in the samples and axial loads. Results: Increase in axial loading caused an increase in the resonance frequency and a simultaneous decrease in vibratory displacement within the sample. At low frequencies (40–80 Hz), increasing the axial load degraded transmissibility; at medium and high frequencies, transmissibility changes were unstable on increasing the axial load. Conclusions: The osseoperception phenomenon is because of perceived prosthesis vibration analysis by the user. Vibration transmissibility of a prosthesis sample depends on the axial compression and frequency of excitation. Decreasing the vibration amplitude while increasing axial load is the primary reason for reduced perception of vibration.